Inhibition of cyclin‐dependent kinase 9 synergistically enhances venetoclax activity in mantle cell lymphoma
Abstract Mantle cell lymphoma (MCL) is an aggressive and largely incurable subtype of non‐Hodgkin's lymphoma. Venetoclax has demonstrated efficacy in MCL patients with relapsed or refractory disease, however response is variable and less durable than CLL. This may be the result of co‐expression of o...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley
2020-07-01
|
| Col·lecció: | eJHaem |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1002/jha2.48 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|